These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 19619018

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: a multicenter, randomized study.
    Chastre J, Wunderink R, Prokocimer P, Lee M, Kaniga K, Friedland I.
    Crit Care Med; 2008 Apr; 36(4):1089-96. PubMed ID: 18379232
    [Abstract] [Full Text] [Related]

  • 3. Medical resource utilization among patients with ventilator-associated pneumonia: pooled analysis of randomized studies of doripenem versus comparators.
    Kollef MH, Nathwani D, Merchant S, Gast C, Quintana A, Ketter N.
    Crit Care; 2010 Apr; 14(3):R84. PubMed ID: 20459721
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of doripenem versus piperacillin/tazobactam in nosocomial pneumonia: a randomized, open-label, multicenter study.
    Réa-Neto A, Niederman M, Lobo SM, Schroeder E, Lee M, Kaniga K, Ketter N, Prokocimer P, Friedland I.
    Curr Med Res Opin; 2008 Jul; 24(7):2113-26. PubMed ID: 18549664
    [Abstract] [Full Text] [Related]

  • 5. Safety of intravenous infusion of doripenem.
    Redman R, File TM.
    Clin Infect Dis; 2009 Aug 15; 49 Suppl 1():S28-35. PubMed ID: 19619019
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Meta-analysis of doripenem vs comparators in patients with pseudomonas infections enrolled in four phase III efficacy and safety clinical trials.
    Jenkins SG, Fisher AC, Peterson JA, Nicholson SC, Kaniga K.
    Curr Med Res Opin; 2009 Dec 15; 25(12):3029-36. PubMed ID: 19849650
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of piperacillin/tazobactam and imipenem/cilastatin, both in combination with tobramycin, administered every 6 h for treatment of nosocomial pneumonia.
    Joshi M, Metzler M, McCarthy M, Olvey S, Kassira W, Cooper A.
    Respir Med; 2006 Sep 15; 100(9):1554-65. PubMed ID: 16487695
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Clinical cure of ventilator-associated pneumonia treated with piperacillin/tazobactam administered by continuous or intermittent infusion.
    Lorente L, Jiménez A, Martín MM, Iribarren JL, Jiménez JJ, Mora ML.
    Int J Antimicrob Agents; 2009 May 15; 33(5):464-8. PubMed ID: 19150225
    [Abstract] [Full Text] [Related]

  • 19. Cost-effectiveness model of empiric doripenem compared with imipenem-cilastatin in ventilator-associated pneumonia.
    Zilberberg MD, Mody SH, Chen J, Shorr AF.
    Surg Infect (Larchmt); 2010 Oct 15; 11(5):409-17. PubMed ID: 20666580
    [Abstract] [Full Text] [Related]

  • 20. Empiric antibiotics pending bronchoalveolar lavage data in patients without pneumonia significantly alters the flora, but not the resistance profile, if a subsequent pneumonia develops.
    Thakkar RK, Monaghan SF, Adams CA, Stephen A, Connolly MD, Gregg S, Cioffi WG, Heffernan DS.
    J Surg Res; 2013 May 15; 181(2):323-8. PubMed ID: 22906560
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.